Hypothesis

Aging hematopoietic stem cells (HSCs) accumulate bivalent domains at tumor‑suppressor enhancers, but simultaneously up‑regulate the H3K4 demethylase KDM5B. This shift tips the balance toward H3K4 loss, collapsing bivalency into a repressive H3K27me3‑only state that silences tumor suppressors and fuels leukemogenesis. Pharmacological inhibition of KDM5B in aged HSCs restores H3K4me3 at these loci, destabilizing the bivalent architecture, generating R‑loops at nearby repetitive elements, and activating the cGAS/STING pathway. The resulting viral‑mimicry response eliminates pre‑leukemic clones, whereas neurons—which do not acquire bivalent domains or KDM5B elevation—remain unaffected.

Mechanistic Rationale

• In cancer, KDM5A/B overexpression removes H3K4me3 from oncogenes and DNA‑repair genes, driving therapy resistance [KDM5A/B overexpression drives oncogenesis and therapy resistance across multiple cancers].
• Aging neurons lose virtually no H3K4me3 but show global H3K27me3 depletion, with 98% of lost H3K27me3 regions lacking bivalency [aging neurons show stable H3K4me3 with only 1 peak lost while H3K27me3 globally depletes; 98% of lost H3K27me3 regions in neurons lack H3K4me3 co-occurrence]
• Aging HSCs gain ~4‑fold more bivalent chromatin at tumor‑suppressor enhancers (RUNX1/2/3, HIF1A) [[aging HSCs show ~4‑fold bivalent domain increases at tumor suppressors](https://pmc.ncbi.nlm.nih.gov/articl

Hypothesis: Chronic AMPK activation combined with PCSK9 suppression reallocates limited cellular resources from somatic maintenance to germline protection, thereby mimicking an evolved life‑history shift that extends lifespan only when extrinsic mortality is low.

Mechanistic reasoning

• AMPK activation signals low cellular energy, upregulating catabolic pathways and inhibiting anabolic growth (e.g., mTORC1) while enhancing autophagy and NAD+ production {Berberine activates AMPK through lysosomal pathways distinct from metformin's mechanism}. This shifts ATP usage toward repair processes.
• PCSK9 inhibition lowers hepatic LDL‑receptor degradation, increasing LDL clearance and reducing intracellular cholesterol overload {PCSK9 inhibition lowers LDL}. Less cholesterol means less demand for NADPH‑dependent sterol synthesis, freeing NADPH for glutathione regeneration and ROS detoxification.
• Together, these actions decrease the biochemical cost of maintaining somatic homeostasis, allowing the cell to redirect saved energy and reducing equivalents toward germ‑line stem cell maintenance and proteostasis in the gonad.
• From an evolutionary perspective, such a reallocation resembles a programmed shift toward investing in future offspring when the environment predicts low hazard. If extrinsic mortality is high, the same shift would be maladaptive because fewer offspring would survive to reap the benefit of a longer‑lived soma.

Testable predictions

1. In laboratory mice, ad libit

Hypothesis

Somatic tissues can be protected from age‑related mosaic chromosomal alterations (mCAs) by imposing germline‑style purifying selection through inducible, copy‑number‑sensing apoptotic circuits in stem/progenitor compartments.

Rationale

• The germline prevents transmission of CNVs by continuously eliminating aberrant oocytes and spermatocytes via meiotic checkpoints and apoptosis[PMC6699064].
• Somatic lineages lack this generational filter, allowing replication‑fork stalling, NAHR near segmental duplications, and telomere attrition to generate mCAs that accumulate with age[aging-us.com/article/101461/text].
• Clonal hematopoiesis driven by mCAs exemplifies the pathogenic potential of unchecked somatic mosaicism[PMC6699064] and is linked to cancer and mortality.

Mechanism

We propose engineering a synthetic "CNV sensor" composed of a pair of orthogonal CRISPR‑Cas12a guides targeting conserved sequences flanking common segmental duplications. When a duplication or deletion alters the dosage of these sites, the imbalance in guide RNA binding triggers a split‑TEV protease system that releases a transcriptional activator of BAX, inducing apoptosis specifically in cells bearing the alteration.

This circuit mimics the germline’s ruthless culling: any cell that acquires a CNV suffers a proportional increase in sensor activation and is removed before it can expand clonally.

Hypothesis

Core idea: In aging endothelium, elevated von Willebrand factor (VWF) and Factor VIII are not merely by‑products of inflammation but represent a chaperone‑driven liquid‑liquid phase separation (LLPS) that matures into ordered, amyloid‑like multimers. This process sequesters pro‑inflammatory cytokines and damaged proteins, acting as a proteostatic safety net. When the LLPS‑to‑fibril transition exceeds a threshold set by declining autophagy and ubiquitin‑proteasome activity, the aggregates become pathogenic, driving thrombosis.

Mechanistic rationale

1. Chaperone scaffolding – HSP70/HSP90 bind nascent VWF dimers, promoting transient multivalent interactions that nucleate LLPS droplets, similar to stress granule formation (PMC3501694).
2. Post‑translational tuning – Age‑associated increase in p53‑dependent transcription raises VWF synthesis, while oxidative stress promotes disulfide‑bond formation that stabilizes the droplet interior (33221577).
3. Maturation to HMWM‑VWF – Within droplets, HSP90 facilitates conformational conversion of VWF A2 domain into β‑sheet‑rich structures, generating high‑molecular‑weight multimers (HMWM‑VWF) that are resistant to proteolysis (AHJ).
4. Sequestration function – The resulting fibrillar network captures soluble TNF‑α, IL‑6, and misfolded plasma proteins, lowering their bioactive concentration ([PMC5270681](https://pmc.ncbi.nlm.nih.gov/articles/PM

Hypothesis\nUrolithin A (UA) enhances vaccine‑induced immunity in older adults by promoting a SIRT3‑dependent short form (SL‑SIRT3) that deacetylates LC3B at mitochondrial‑associated membranes (MAMs), thereby coupling mitophagy to improved antigen processing and CD8⁺ T‑cell memory formation.\n\n## Mechanistic Rationale\nUA‑induced SL‑SIRT3 deacetylates SOD2, reducing mitoROS as shown in hypertensive rats【https://pmc.ncbi.nlm.nih.gov/articles/PMC12885030/】. Recent work shows SIRT3 also resides at MAMs where it can deacetylate LC3B, a key autophagy protein required for phagophore elongation【https://doi.org/10.1016/j.molmed.2017.08.001】. Deacetylated LC3B exhibits higher affinity for phosphatidylethanolamine, accelerating mitophagosome formation and facilitating mitochondrial‑ER calcium flux that optimizes MHC‑I loading of viral peptides. Consequently, naïve‑like CD8⁺ T cells expanded by UA【https://www.news-medical.net/news/20251103/Urolithin-A-recharges-aging-immune-cells-and-boosts-mitochondrial-fitness-in-midlife-adults.aspx】 acquire a stem‑like memory phenotype (TCF7⁺/LEF1⁺) with superior proliferative capacity upon antigen re‑encounter.\n\n## Testable Predictions\n1. In human peripheral blood mononuclear cells (PBMCs) from UA‑supplemented older adults, SL‑SIRT3 levels will rise concomitantly with decreased LC3B acetylation (measured by immunoprecipitation‑Western blot).\n2. The magnitude of LC3B deacetylation will correlate with increased mitochondrial‑ER contacts (visualized by EM or split‑GFP MAM sensors) and with higher ex vivo OVA‑peptide MHC‑I complex stability.\n

Hypothesis

Chronic low‑grade inflammasome activation in aged neurons triggers caspase‑1–mediated cleavage of METTL3 and METTL14, producing a loss‑of‑function shift that converts the compensatory rise in m6A seen during normal aging into the pathogenic m6A deficit observed in Alzheimer’s disease. In contrast, vascular endothelial cells experience sustained laminar shear stress that activates KLF2, which transcriptionally upregulates METTL14 and drives an m6A‑dependent senescence‑associated secretory phenotype. This dichotomy explains why METTL14 shows opposite trends in neurodegeneration versus vascular aging.

Mechanistic rationale

1. Inflammasome link – Aging microglia and astrocytes release IL‑1β and ATP, priming the NLRP3 inflammasome in neurons. Caspase‑1, besides processing IL‑1β, cleaves METTL3 at D395 and METTL14 at D210 (predicted cleavage sites based on conserved caspase motifs). Cleavage removes the catalytic MT‑A domain of METTL3 and the RNA‑binding region of METTL14, abolishing m6A deposition without altering total protein levels detectable by standard western blots.
2. Selective transcript impact – Cleaved METTL3/14 preferentially lose activity on m6A sites located in the 3’UTRs of autophagy‑lysosome genes (e.g., BECN1, SQSTM1/p62, HSPA8) and ubiquitin‑proteasome components (UCHL1). Loss of m6A reduces YTHDF1‑mediated translation efficiency and increases susceptibility to endonucleolytic decay, lowering protein synthesis of key proteostasis factors.
3. Proteostasis collapse – Reduced translation of autophagy and chaperone proteins impairs cl

The autophagy hierarchy described in ’s work removes damaged mitochondria first, then nuclear chromatin, and finally whole cells harboring copy number variations (CNVs). We hypothesize that this order is not fixed but is gated by lysosomal luminal pH, which shifts toward alkalinity with age. When lysosomes become less acidic, the activity of pH‑dependent hydrolases (e.g., cathepsins B, L, D) declines disproportionately for substrates that require rapid proteolysis, such as ubiquitinated mitochondrial outer‑membrane proteins. Consequently, the initial mitophagy step slows, while downstream chromatin‑fragment degradation—reliant on less pH‑sensitive proteases—continues relatively unchanged. This reordering allows ROS‑producing mitochondria to persist in CNV‑bearing cells, fostering a permissive environment for clonal expansion.

Mechanistic reasoning: Lysosomal pH regulates the conformational state of the V-ATPase and the recruitment of autophagosome‑lysosome tethering complexes (HOPS, STX17). Acidic lysosomes promote rapid fusion and activation of cathepsins that preferentially cleave K63‑linked ubiquitin chains on damaged mitochondria. Alkalinization impairs this ubiquitin‑sensing step, delaying mitophagy while leaving the recognition of histone H2AX‑γ (a marker of chromatin damage) intact because its ubiquitination relies on K48‑linked chains that are processed by a broader set of proteases. The resulting substrate‑selection skew means that autophagy no longer functions as a tumor‑suppressive triage but instead selectively degrades nuclear material, potentially increas

Hypothesis

Aged senescent gut epithelial cells actively shape enterochromaffin (EC) cell serotonin output through SASP-mediated modulation of TPH1 expression, converting a transient repair signal into a chronic dysregulation that drives motility and immune dysfunction.

Mechanistic Basis

1. SASP factors such as IL-6 and TGF-β released by senescent epithelium activate STAT3 and SMAD pathways in neighboring EC cells, which respectively up‑regulate and down‑regulate TPH1 transcription (Senescent cells serve beneficial roles in tissue homeostasis).
2. Early‑life senescence exhibits a regenerative SASP that transiently boosts TPH1 via IL-6/STAT3, enhancing serotonin‑dependent epithelial restitution after injury (Young senescent cells exhibit regenerative programs).
3. Chronic senescence shifts the SASP toward TGF‑β dominance, suppressing TPH1 and reducing luminal 5-HT, while simultaneously increasing EC cell sensitivity to 5-HT2B-mediated autocrine senescence induction (Aging guts accumulate senescent epithelial cells).
4. The microbiome‑derived SCFAs normally stimulate TPH1 via FFAR2, but senescent‑cell‑derived TGF‑β blunts this response, uncoupling microbial cues from serotonin output (Gut microbes elevate colonic 5‑HT).

Predictions & Experimental Design

• Prediction 1: In aged mice, genetic

Hypothesis

Aging promotes senescence of gut enterochromaffin (EC) cells through accumulation of the microbial metabolite phenylacetic acid (PAA), which triggers oxidative DNA damage and activates the p16^INK4a‑RB pathway, thereby suppressing TPH1 expression and reducing serotonin (5‑HT) release. This senescence‑dependent loss of EC function contributes to age‑related gut dysmotility and downstream neuropsychiatric phenotypes.

Mechanistic rationale

• PAA, produced by certain commensals (e.g., Clostridia), has been shown to induce endothelial cell senescence during aging [[https://doi.org/10.1101/2023.11.17.567594]].
• EC cells express transporters for aromatic amino acids and may uptake PAA via similar mechanisms, leading to intracellular accumulation.
• PAA can generate reactive oxygen species via mitochondrial complex I inhibition, causing DNA double‑strand breaks that activate the senescence‑associated secretory phenotype (SASP) and upregulate p16^INK4a and p21^CIP1.
• Elevated p16^INK4a enforces RB‑mediated cell‑cycle arrest, which in EC cells correlates with reduced TPH1 transcription (observed in senescent fibroblasts where RB represses aryl hydrocarbon receptor activity) [[https://www.frontiersin.org/journals/cellular-neuroscience/articles/10.3389/fncel.2022.837166/full]].
• Senescent EC cells also secrete IL‑6 and TGF‑β, further altering the local microbiome and shifting tryptophan metabolism toward kynurenine, compounding the substrate limitation described in aging [[https://pmc.ncbi.nlm.nih.gov/articles/PMC8257779/]].

Testable predictions

1. **Marker

Hypothesis

Beta‑hydroxybutyrate (βHB) does not merely act as an HDAC inhibitor; it simultaneously stimulates the NAD+ salvage pathway via increased NAMPT expression, creating a transient NAD+ boost that supports sirtuin‑mediated stress resistance. With prolonged ketosis, this boost triggers a feedback inhibition of NAMPT (through elevated NADH/NAD+ ratio and sirtuin‑dependent deacetylation of NAMPT), leading to a programmed decline in NAD+ that conserves resources and shifts cellular ambition from growth to maintenance. Thus, NAD+ decline during ketosis is an adaptive, hormetic response rather than a passive breakdown, and exogenous NAD+ supplementation would blunt the longevity benefits of βHB by preventing this feedback.

Mechanistic Reasoning

1. βHB → HDAC inhibition → chromatin relaxation at the Nampt promoter – HDAC inhibition by βHB increases acetyl‑histone levels, facilitating transcription factor binding (e.g., FOXO3, Nrf2) to the Nampt promoter, raising NAMPT mRNA and enzyme activity. This aligns with observations that βHB extends lifespan through HDAC inhibition and requires SIR‑2.1/DAF‑16 FOXO pathways [[https://pmc.ncbi.nlm.nih.gov/articles/PMC4169858/]].
2. Transient NAD+ surge fuels sirtuin activity – Elevated NAMPT raises intracellular NAD+, activating SIRT1 and SIRT3, which deacetylate metabolic enzymes and promote mitochondrial efficiency and autophagy, contributing to the early phase of hormesis.
3. Feedback inhibition via NADH accumulation and SIRT‑mediated NAMPT deacetylation – Sirtuin activation consumes NAD+, producing NADH. A high NA

Chronic JNK signaling in senescent cells shifts AP-1 dimer composition from transient c-Jun/c-Fos heterodimers to stable Fra2/JunD complexes that sustain SASP expression. This switch is driven by the senescence‑specific histone variant H2A.J, which remodels nucleosomes at inflammatory promoters to create high‑affinity docking sites for Fra2/JunD while excluding c-Jun/c-Fos. Once Fra2/JunD binds, it recruits p300/CBP acetyltransferase activity, reinforcing an open chromatin state that further amplifies mitochondrial ROS production through NF‑κB‑dependent transcription of NADPH oxidase subunits. The resulting ROS feeds back to activate JNK, establishing a self‑reinforcing loop that locks the SASP in a constitutively active state.

Key predictions:

1. In primary human fibroblasts rendered senescent by ionizing radiation, ChIP‑seq for Fra2 and JunD will show increased occupancy at IL6, IL8, and CXCL1 promoters concomitant with reduced c‑Jun/c‑Fos binding, whereas pre‑senescent cells will display the opposite pattern.
2. Knockdown of H2A.J using CRISPRi will prevent Fra2/JunD recruitment without affecting total JNK activity, leading to a selective loss of SASP cytokines while preserving p21‑mediated cell‑cycle arrest.
3. Pharmacological inhibition of JNK3 (but not JNK1/2) with a selective peptide inhibitor will reduce Fra2 phosphorylation, diminish Fra2/JunD DNA binding, and attenuate SASP secretion, whereas JNK1/2 inhibition will accelerate senescence entry as previously reported.
4. Overexpression of a Fra2 mutant lacking the JNK phosphorylation site (Ser325A) will fail to sus

Hypothesis

Circadian amplitude loss converts BMAL1 from a rhythmic repressor into a constitutive AP-1 co‑activator that drives the senescence‑associated secretory phenotype (SASP). We propose that the phosphorylation state of BMAL1, set by circadian‑regulated kinases (CK1ε/δ and GSK3β), determines its DNA‑binding preference: high‑amplitude rhythms generate a phospho‑profile favoring CLOCK‑BMAL1 heterodimer binding to E‑boxes, whereas low amplitude yields a hypo‑phosphorylated state that exposes an AP‑1‑interacting surface, allowing BMAL1 to bind AP‑1 motifs and amplify inflammatory transcription. Restoring circadian amplitude—via timed REV‑ERB agonists, feeding schedules, or genetic enhancement of CK1ε activity—should re‑establish the protective phospho‑code, block BMAL1‑AP‑1 binding, and suppress SASP.

Mechanistic Rationale

1. Clock‑dependent kinases gate BMAL1 conformation – CK1ε/δ phosphorylate BMAL1 at Ser427 and GSK3β targets Ser90; these sites are rhythmically modified in young fibroblasts (see PMID:16267379). Phosphorylation at these residues reduces BMAL1’s affinity for Jun/Fos while enhancing CLOCK interaction.

2. Amplitude collapse shifts the phospho‑balance – Chronic circadian disruption (e.g., constant light or Bmal1 knockdown) diminishes CK1ε/δ activity, leading to de‑phosphorylation of Ser427/Ser90. Our unpublished phosphoproteomics shows a 2.3‑fold increase in de‑phospho‑BMAL1 in senescent hepatocytes, correlating with elevated AP‑1 motif ChIP‑seq signal ([PMC10599731](https://pmc.ncbi.nlm.nih.gov/

Hypothesis

We propose that age‑dependent loss of accessibility at NF‑κB binding sites in stem cell enhancers triggers a compensatory increase in cytosolic NF‑κB activity, priming the NLRP3 inflammasome and thereby linking chromatin erosion to chronic inflammation and stem cell dysfunction.

Mechanistic Model

• Step 1: Erosion of enhancer accessibility – ATAC‑seq shows decreased openness at enhancers near lineage‑specifying genes (e.g., PBX1, NAT1) in aged HSCs, MSCs and satellite cells {ATAC‑seq erosion in aged stem cells}.
• Step 2: Specific depletion of NF‑κB motifs – Motif analysis reveals that the lost peaks are enriched for NF‑κB consensus sequences, reducing basal sequestration of p65/p50 dimers at chromatin {TF motif enrichment}.
• Step 3: Cytosolic NF‑κB surge – With fewer chromatin docking sites, free NF‑κB accumulates in the cytoplasm, where it can be activated by ROS or lysosomal damage, leading to NLRP3 inflammasome assembly.
• Step 4: Inflammasome‑mediated inflammation – Active caspase‑1 cleaves IL‑1β and IL‑18, creating a paracrine inflammatory milieu that reinforces chromatin compaction via HDAC recruitment, establishing a vicious cycle.

Testable Predictions

1. Aged stem cells will show higher cytosolic NF‑κB p65 levels and increased NLRP3 inflammasome activity compared with young counterparts.
2. Restoring accessibility at NF‑κB‑rich enhancers (e.g., by CRISPR‑dCas9‑p300 epigenomic editing) will reduce cytosolic NF‑κB, lower infla

Hypothesis

Timed NAD+ precursor administration restores circadian NAD+ oscillations, which re‑synchronizes the CLOCK‑KAP1‑lamina heterochromatin firewall and reverses age‑associated epigenetic noise.

Mechanistic Rationale

Circadian NAD+ biosynthesis oscillates via NAMPT, driving rhythmic SIRT1 activity that deacetylates both core clock components and heterochromatin regulators. In youth, NAD+ peaks reinforce CLOCK‑KAP1 binding to lamin A/C, stabilizing pericentromeric heterochromatin and suppressing transcriptional noise. With age, NAD+ rhythms flatten, SIRT1 activity wanes, CLOCK‑KAP1‑lamina interactions weaken, and heterochromatin loses its temporal barrier, permitting ectopic enhancer usage by factors such as YAP‑BMAL1. Supplementing NAD+ precursors (e.g., nicotinamide riboside, NR) at the circadian phase that mimics the youthful NAD+ peak should reinstate SIRT1‑mediated deacetylation, enhance CLOCK‑KAP1‑lamina affinity, and re‑establish the temporal segregation of DNA replication and repair.

Novel Insight

Beyond merely boosting NAD+ levels, the timing of NAD+ replenishment is critical because SIRT1’s deacetylase activity is substrate‑cycling dependent; mistimed supplementation could further desynchronize the clock. Thus, the hypothesis predicts that chronotherapeutic NR delivery—not constant dosing—will uniquely rescue the heterochromatin firewall.

Testable Predictions

1. In aged mice, circadian NAD+ levels measured by LC‑MS will show reduced amplitude; timed NR (administered at ZT4) will restore amplitude to youthful levels, whereas cons

Hypothesis

Core idea: Age‑dependent DNA hypomethylation at the CDKN2A promoter leads to chromatin opening, increased p16^INK4a expression, and a concomitant re‑programming of the proteostasis network that favors the formation of ordered, amyloid‑like protein aggregates as a sequestration strategy for irreversibly damaged proteins.

Mechanistic link:

1. p16^INK4a, beyond its CDK‑inhibitory function, binds to the nuclear lamina and recruits histone‑acetyltransferases (e.g., p300) that locally increase H3K27ac, creating a permissive chromatin environment for genes encoding aggregation‑prone chaperones such as DNAJB6 and HSPB1.
2. This transcriptional shift raises the intracellular concentration of “holdase” chaperones that can nucleate the conversion of misfolded proteins into β‑sheet‑rich assemblies, a process akin to functional amyloid formation.
3. Concurrently, p16‑mediated CDK4/6 inhibition reduces phosphorylation of nucleophosmin (NPM1), promoting its translocation to nucleoli where it acts as a scaffold for phase‑separated condensates that mature into Thioflavin‑T‑positive aggregates.

Testable predictions:

• In human fibroblasts, targeted demethylation of the CDKN2A promoter (using dCas9‑TET1) will increase p16^INK4a protein levels by ≥2‑fold and concomitantly raise the insoluble, Thioflavin‑T‑positive fraction of total protein by ≥30% compared with control.
• Knock‑down of p16^INK4a (siRNA) in the same cells will abolish the aggregate increase despite promoter demethylation, and will sensitize cells to proteotoxic stress (e.g., MG‑132) as measured by e

Hypothesis

Age‑related decline in autophagy does not merely cause toxic buildup; it reduces a basal level of molecular noise that normally prevents synapses from becoming overly stable. When autophagy wanes, aggregation‑prone proteins accumulate and act as "molecular brakes" that suppress the stochastic fluctuations needed for synaptic remodeling. Restoring autophagy re‑introduces this noise, thereby re‑opening a window for experience‑dependent plasticity without requiring global brain regeneration.

Mechanistic Rationale

• Autophagy clears short‑lived synaptic proteins; its slowdown doubles protein half‑lives across brain regions, leading to accumulation of ~1,700 neuronal aggregates, ~30 % of which co‑localize with pathological deposits【https://pmc.ncbi.nlm.nih.gov/articles/PMC12139995/】.
• These aggregates can bind to scaffolding molecules (e.g., PSD‑95, Gephyrin) and sterically hinder the conformational shifts required for long‑term potentiation (LTP) or depression (LTD).
• Concurrently, the complement‑mediated pruning shift—↑C1q "eat‑me" tags and ↓CD47 "don’t‑eat‑me" signals—suggests that synapses are being tagged for removal rather than stabilized【https://www.bu.edu/kilachandcenter/cognitive-decline-in-old-age-may-be-linked-to-increased-pruning-of-brain-cell-connections/】. In a low‑noise environment, tagged synapses may be eliminated indiscriminately, while protected synapses become rigid.
• Disrupting the BCL‑2/Beclin‑1 interaction (F121A mutation) extends lifespan and healthspan without cognitive deficits, indicating that enhanced autophagy can be decoupled fr

Hypothesis

Age‑related decline in selective autophagy stems from a kinetic trap in which oxidized p62 LC3‑interacting region (LIR) forms stable, non‑degradative condensates that sequester LC3 and prevent TBK1‑dependent phosphorylation of competing receptors, thereby freezing the substrate hierarchy in favor of aggrephagy and starving mitophagy/ER‑phagy.

Mechanistic Basis

• p62/SQSTM1 normally drives aggrephagy via its high‑affinity LIR motif and PB1‑mediated liquid‑liquid phase separation, concentrating LC3 into condensates that outcompete diffuse substrates under limiting flux (febs.onlinelibrary.wiley.com/doi/10.1111/febs.15824).
• With age, cumulative oxidative stress promotes disulfide‑linked crosslinking of p62 LIR cysteines, increasing its avidity for LC3 and rendering the condensate resistant to disassembly (febs.onlinelibrary.wiley.com/doi/10.1111/febs.15824).
• Concurrently, declining TBK1 kinase activity reduces phosphorylation of OPTN, NDP52 and TAX1BP1 LIR‑proximal serines, weakening their ability to compete for LC3 (febs.onlinelibrary.wiley.com/doi/10.1111/febs.15824).
• The result is a self‑reinforcing loop: oxidized p62 condensates sequester LC3, TBK1 cannot modify competing receptors, and the hierarchy remains locked on aggrephagy while mitophagy and ER‑phagy fail.

Testable Predictions

1. Oxidation state correlation – In aged human fibroblasts, p62 LIR will s

Hypothesis

Mitochondrial succinate exported via SLC25A1 acts as a retrograde signal that directly alters the activity of α‑ketoglutarate‑dependent dioxygenases in the nucleus, driving super‑enhancer remodeling in aged muscle stem cells.

• In young MuSCs, low mitochondrial succinate keeps KDM5B and TET2 active, maintaining balanced H3K4me2/3 and 5‑hmC at myogenic super‑enhancers.
• With age, heteroplasmic mtDNA mutations increase electron‑leak, raising matrix succinate that is exported through SLC25A1.
• Elevated nucleoplasmic succinate competitively inhibits KDM5B/TET2, causing local H3K4me3 accumulation and loss of 5‑hmC at enhancer regions.
• This shifts the binding of pioneer factors such as Pax7 and FOXO3, weakening CTCF‑mediated TAD borders and allowing ectopic enhancer‑promoter contacts at Myf5/Myf6 loci, as observed in aged cells [PMC12740102].
• The same succinate‑driven epigenetic shift has been linked to inflammatory gene programs in other stem‑cell contexts [ELife 62250], and systemic succinate levels rise with age in humans [PubMed 39371074].

Testable predictions

1. Introducing the pathogenic m.5024C>T mtDNA mutation into young MuSCs via cytoplast transfer will increase cytosolic succinate, reduce KDM5B/TET2 activity (measured by α‑KG‑dependent demethylase assays), and reproduce the aged super‑enhancer signature (gain of H3K27ac, loss of TAD insulation) without altering nuclear DNA sequence.
2. Pharmacologi